Jasper Therapeutics
Enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.
Launch date
Employees
Market cap
€292m
Enterprise valuation
€197m (Public information from Sep 2024)
Share price
$23.91 JSPR
Redwood City California (HQ & founding location)
Authorizing premium user...